China Regenerative Medicine International Limited
8158.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$94.32M
Close$
Share Statistics
| Market cap | $94.32 Million |
|---|---|
| Enterprise Value | $143.67 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | -0.67 |
| Outstanding Shares | 304,252,000 |
Return
| Return on Equity | 52.59% |
|---|---|
| Return on Assets | 20.84% |
| Return on Invested Capital | 11.66% |
Valuation & Multiples
| P/E Ratio | 3.16 |
|---|---|
| PEG | 3.14 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.34 |
| Enterprise Value to EBIT | 14.88 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Regenerative Medicine International Limited
33 employees
CEO: Chuang Wang China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensiv...